Alnylam Pharmaceuticals(ALNY) - 2019 Q1 - Quarterly Report
Alnylam Pharmaceuticals(ALNY)2019-05-03 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-----------------------------------------------------------------------------------|-----------------------| | For the transition period from ___________ to ___________ | | | Commission ...